Radiotherapy after breast-conserving surgery can be safely omitted in certain older women with low-risk, hormone receptor-positive early breast cancer receiving adjuvant endocrine therapy, 10-year results of the PRIME II trial showed.
Source: The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has recently reached 65,000 participants. Which surpasses the halfway mark toward its current goal of 128,905. Organisers said on Friday that enrolment had doubled over the last year and a half, with Black women accounting for more than 20% of enrolment.
GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.
Subscribe to our newsletter
LET US PROVIDE YOU WITH THE LATEST MEDICAL NEWS, NETWORKING AND PROFESSIONAL
DEVELOPMENT OPPORTUNITIES, AND EXCITING JOB OPENINGS FOR RADIOLOGISTS.